Dexin Corporation (TPEX:3349)
Taiwan · Delayed Price · Currency is TWD 25.50
+0.15 (0.59%)
At close: Mar 26, 2026
Dexin Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 479.32 | 453.99 | 387.42 | 552.01 | 1,231 | |
Revenue Growth (YoY) | 5.58% | 17.18% | -29.82% | -55.17% | 51.35% |
Cost of Revenue | 383.07 | 367.11 | 345.54 | 474.62 | 996.14 |
Gross Profit | 96.25 | 86.88 | 41.88 | 77.39 | 235.08 |
Selling, General & Admin | 72.41 | 79.23 | 81.76 | 96.15 | 115.4 |
Research & Development | 52.55 | 68.51 | 54.28 | 56.96 | 49.98 |
Operating Expenses | 122.12 | 154.42 | 155.33 | 142.23 | 165.24 |
Operating Income | -25.87 | -67.54 | -113.45 | -64.85 | 69.84 |
Interest Expense | -3.2 | -4.97 | -6.87 | -7.23 | -6.79 |
Interest & Investment Income | 1.15 | 1.52 | 2.22 | 0.79 | 0.11 |
Earnings From Equity Investments | -0.61 | -0.43 | -2.49 | -1.4 | 0.56 |
Currency Exchange Gain (Loss) | - | 13.97 | -0.24 | 18.21 | -4.98 |
Other Non Operating Income (Expenses) | -6.2 | 10.78 | 9.42 | 8.57 | 11.83 |
EBT Excluding Unusual Items | -34.72 | -46.67 | -111.41 | -45.9 | 70.57 |
Gain (Loss) on Sale of Assets | - | -3.81 | - | 0.15 | 0.17 |
Other Unusual Items | - | 7.16 | 3.16 | 0.01 | 0 |
Pretax Income | -34.72 | -43.32 | -108.25 | -45.75 | 70.74 |
Income Tax Expense | 9.17 | -1.16 | -13.47 | 5.02 | 10.58 |
Net Income | -43.89 | -42.16 | -94.78 | -50.76 | 60.16 |
Net Income to Common | -43.89 | -42.16 | -94.78 | -50.76 | 60.16 |
Net Income Growth | - | - | - | - | 181.38% |
Shares Outstanding (Basic) | 43 | 40 | 40 | 39 | 35 |
Shares Outstanding (Diluted) | 43 | 40 | 40 | 39 | 35 |
Shares Change (YoY) | 7.39% | - | 2.61% | 10.01% | 0.21% |
EPS (Basic) | -1.02 | -1.05 | -2.37 | -1.30 | 1.70 |
EPS (Diluted) | -1.02 | -1.05 | -2.37 | -1.30 | 1.69 |
EPS Growth | - | - | - | - | 179.47% |
Free Cash Flow | 71.81 | -62.03 | -88.11 | -12.27 | 84.17 |
Free Cash Flow Per Share | 1.67 | -1.55 | -2.20 | -0.31 | 2.37 |
Dividend Per Share | - | - | - | - | 0.769 |
Dividend Growth | - | - | - | - | 389.31% |
Gross Margin | 20.08% | 19.14% | 10.81% | 14.02% | 19.09% |
Operating Margin | -5.40% | -14.88% | -29.28% | -11.75% | 5.67% |
Profit Margin | -9.16% | -9.29% | -24.46% | -9.20% | 4.89% |
Free Cash Flow Margin | 14.98% | -13.66% | -22.74% | -2.22% | 6.84% |
EBITDA | 3.26 | -50.78 | -97.81 | -50.38 | 83.11 |
EBITDA Margin | 0.68% | -11.19% | -25.25% | -9.13% | 6.75% |
D&A For EBITDA | 29.13 | 16.76 | 15.64 | 14.46 | 13.27 |
EBIT | -25.87 | -67.54 | -113.45 | -64.85 | 69.84 |
EBIT Margin | -5.40% | -14.88% | -29.28% | -11.75% | 5.67% |
Effective Tax Rate | - | - | - | - | 14.96% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.